• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers

    3/13/25 1:00:00 AM ET
    $HIMS
    $RKLB
    Medical/Nursing Services
    Health Care
    Military/Government/Technical
    Industrials
    Get the next $HIMS alert in real time by email

    MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs introduces RKLX and HIMZ, two 2X leveraged single-stock ETFs designed to provide amplified exposure to Rocket Lab USA, Inc. (NASDAQ:RKLB) and Hims & Hers Health Inc. (NYSE:HIMS). These ETFs offer traders a way to seek enhanced returns on Rocket Lab and Hims & Hers without requiring a margin account.

    • RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab, a company at the forefront of satellite launches, space exploration, and advanced aerospace systems.
    • HIMZ, the Defiance Daily Target 2X Long HIMS ETF, seeks daily investment results that correspond to twice (200%) the daily return of Hims & Hers, a company pioneering telehealth and direct-to-consumer healthcare solutions.

    "RKLX and HIMZ offer compelling opportunities for investors seeking amplified exposure to Rocket Lab and Hims & Hers, two companies driving innovation in their respective industries," said Sylvia Jablonski, CEO of Defiance ETFs. "With increasing demand for satellite technology and digital healthcare solutions, Rocket Lab and Hims & Hers continue to play key roles in shaping the future of space exploration and telehealth."

    For more information, visit DefianceETFs.com

    These Funds are not intended to be used by, and are not appropriate for, investors who do not intend to actively monitor and manage their portfolios. The Funds pursue a daily leveraged investment objective, making them riskier than alternatives that do not use leverage, as they magnify the performance of their respective underlying securities. These Funds are not suitable for all investors. They are designed for knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, recognize the risks associated with the use of leverage, and are willing to frequently monitor their portfolios. Over periods longer than a single day, the Funds may lose value even if their underlying securities increase in performance, and they will lose value if the underlying securities remain flat. An investor could lose the full principal value of their investment within a single day.

    An investment in RKLX is not an investment in Rocket Lab USA, Inc. An investment in HIMZ is not an investment in Hims & Hers Health Inc.

    About Defiance ETFs

    Founded in 2018, Defiance is at the forefront of ETF innovation. Defiance is a leading ETF issuer specializing in thematic, income, and leveraged ETFs.

    Our first-mover leveraged single-stock ETFs empower investors to take amplified positions in high-growth companies, providing precise leverage exposure without the need to open a margin account.

    IMPORTANT DISCLOSURES

    Defiance ETFs LLC is the ETF sponsor. The Fund's investment adviser is Tidal Investments, LLC ("Tidal" or the "Adviser").

    The Funds' investment objectives, risks, charges, and expenses must be considered carefully before investing. The prospectus and summary prospectus contain this and other important information about the investment company. Please read carefully before investing. A hard copy of the prospectuses can be requested by calling 833.333.9383.

    Investing involves risk. Principal loss is possible. As an ETF, the funds' may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. A portfolio concentrated in a single industry or country, may be subject to a higher degree of risk.

    RKLB and HIMS Risks: The Fund invests in swap contracts and options that are based on the share price of HIMS. This subjects the Fund to certain of the same risks as if it owned shares of HIMS even though it does not.

    Indirect Investment Risk. RKLB and HIMS are not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and are not involved with this offering in any way and have no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares.

    Trading Risk. The trading price of the fund may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading RKLB and HIMS potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company's control may influence RKLB's and HIMS's stock price disproportionately.

    Performance Risk. RKLB and HIMS may fail to meet publicly announced guidelines or other expectations about its business, which could cause the price of RKLB and HIMS to decline.

    RKLB Aerospace & Defense Industry Risks. Companies in the aerospace and defense industry are subject to risks stemming from their reliance on government budgets and spending priorities, which can fluctuate due to political and economic pressures. The aerospace and defense industry is also affected by geopolitical tensions, trade policies, and regulatory changes that can impact market access and operational efficiency. Aerospace and defense companies typically rely on complex supply chains for specialized components and materials. Additionally, technological advancements are critical for maintaining competitiveness in this sector, but the high cost and uncertain outcomes of research and development efforts may pose financial risks. Companies in this industry face heightened cybersecurity risks due to the sensitive nature of their technologies, and breaches can lead to operational disruptions, reputational damage, and regulatory scrutiny. 

    RKLB Business Risks. RKLB has experienced rapid growth, with its employee base and operations expanding substantially in recent years, placing considerable demands on its management, operational infrastructure, and financial resources. Continued growth is dependent on RKLB's ability to scale its revenue, improve operational efficiencies, and maintain profitability while effectively managing its increasingly complex organizational structure. Additionally, interruptions from information technology failures, cybersecurity breaches, or other infrastructure issues could disrupt operations. RKLB's ability to comply with applicable regulations and adapt to changes in the industry also presents ongoing risks.

    HIMS Healthcare Providers & Services Industry Risks. The healthcare providers and services industry can be significantly affected by changing economic conditions, evolving patient demographics, and fluctuations in demand for healthcare services. Changes in healthcare regulations and policies, including those related to insurance coverage and reimbursement, can materially impact the industry. Additionally, the industry faces risks related to litigation, operational disruptions, and evolving technologies that may alter traditional service delivery models.

    HIMS Business Risks. HIMS operates in highly competitive markets, facing challenges from established healthcare providers, retailers, pharmaceutical companies, and technology firms, which may affect its competitive position. Additionally, the success of HIMS is heavily reliant on its brand reputation, relationships with healthcare providers and medical groups, and compliance with complex healthcare and pharmacy regulations. Security breaches, data loss, legal proceedings, or regulatory changes could harm its operations and reputation.

    RKLX and HIMZ Fund Risks 

    Leverage Risk. The Fund obtains investment exposure in excess of its net assets by utilizing leverage and may lose more money in market conditions that are adverse to its investment objective than a fund that does not utilize leverage. An investment in the Fund is exposed to the risk that a decline in the daily performance of the Underlying Security will be magnified.

    High Portfolio Turnover Risk. Daily rebalancing of the Fund's holdings pursuant to its daily investment objective causes a much greater number of portfolio transactions when compared to most ETFs.

    Liquidity Risk. Some securities held by the Fund may be difficult to sell or be illiquid, particularly during times of market turmoil. Markets for securities or financial instruments could be disrupted by a number of events, including, but not limited to, an economic crisis, natural disasters, epidemics/pandemics, new legislation or regulatory changes inside or outside the United States.

    Derivatives Risk. The Fund's investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other ordinary investments, including risk related to the market, leverage, imperfect daily correlations with underlying investments or the Fund's other portfolio holdings, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions.

    Compounding and Market Volatility Risk. The Fund has a daily leveraged investment objective and the Fund's performance for periods greater than a trading day will be the result of each day's returns compounded over the period, which is very likely to differ from two times (200%) the Underlying Security's performance, before the Fund's management fee and other expenses.

    Fixed Income Securities Risk. When the Fund invests in fixed income securities, the value of your investment in the Fund will fluctuate with changes in interest rates. Typically, a rise in interest rates causes a decline in the value of fixed income securities owned by the Fund.

    Single Issuer Risk. Issuer-specific attributes may cause an investment in the Fund to be more volatile than a traditional pooled investment which diversifies risk of the market generally. The value of the Fund, which focuses on an individual security, may be more volatile than a traditional pooled investment or the market as a whole and may perform differently from the value of a traditional pooled investment or the market as a whole.

    New Fund Risk. The Fund is a recently organized management investment company with no operating history. As a result, prospective investors do not have a track record or history on which to base their investment decisions.

    Diversification does not ensure a profit nor protect against loss in a declining market.

    Brokerage Commissions may be charged on trades.

    Distributed by Foreside Fund Services, LLC

    Contact Information

    David Hanono

    [email protected]

    833.333.9383

    A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/25cf1c68-b060-42fa-b3cf-e1315eea5f0e



    Get the next $HIMS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HIMS
    $RKLB

    CompanyDatePrice TargetRatingAnalyst
    Rocket Lab Corporation
    $RKLB
    7/28/2025$51.00Hold
    Craig Hallum
    Rocket Lab Corporation
    $RKLB
    6/30/2025$27.00Neutral
    Goldman
    Hims & Hers Health Inc.
    $HIMS
    6/23/2025Buy → Hold
    Needham
    Hims & Hers Health Inc.
    $HIMS
    6/4/2025$61.00 → $65.00Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    4/29/2025$30.00Buy → Hold
    TD Cowen
    Rocket Lab Corporation
    $RKLB
    4/25/2025$28.00Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    2/18/2025$42.00 → $60.00Overweight → Equal-Weight
    Morgan Stanley
    Hims & Hers Health Inc.
    $HIMS
    1/10/2025$24.00 → $25.00Neutral → Sell
    Citigroup
    More analyst ratings

    $HIMS
    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CEO and Chairman Beck Peter sold $127,453,446 worth of shares (2,500,000 units at $50.98) (SEC Form 4)

    4 - Rocket Lab Corp (0001819994) (Issuer)

    9/17/25 9:13:36 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Chief Medical Officer Carroll Patrick Harrison converted options into 16,521 shares and covered exercise/tax liability with 6,500 shares, increasing direct ownership by 6% to 179,961 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    9/17/25 7:25:10 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    PAO Becklund Irene covered exercise/tax liability with 8,867 shares and converted options into 17,983 shares, increasing direct ownership by 1,280% to 9,828 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    9/17/25 7:24:58 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    SEC Filings

    View All

    SEC Form 144 filed by Rocket Lab Corporation

    144 - Rocket Lab Corp (0001819994) (Subject)

    9/17/25 4:21:19 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    SEC Form 144 filed by Rocket Lab Corporation

    144 - Rocket Lab Corp (0001819994) (Subject)

    9/16/25 9:07:49 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    SEC Form 144 filed by Rocket Lab Corporation

    144 - Rocket Lab Corp (0001819994) (Subject)

    9/16/25 8:51:36 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $HIMS
    $RKLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Manuel Anja bought $132,260 worth of shares (5,000 units at $26.45) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    11/14/24 4:57:45 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Payne Christopher D bought $1,951,763 worth of shares (110,000 units at $17.74) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    5/22/24 4:16:26 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on Rocket Lab USA with a new price target

    Craig Hallum initiated coverage of Rocket Lab USA with a rating of Hold and set a new price target of $51.00

    7/28/25 8:27:22 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Goldman resumed coverage on Rocket Lab USA with a new price target

    Goldman resumed coverage of Rocket Lab USA with a rating of Neutral and set a new price target of $27.00

    6/30/25 8:06:32 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Hims & Hers Health downgraded by Needham

    Needham downgraded Hims & Hers Health from Buy to Hold

    6/23/25 11:43:05 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

    Through a major health platform exclusive collaboration with Marius Pharmaceuticals and more, the company is expanding access to innovative testosterone treatments Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the launch of a new category in men's health, offering access to innovative, affordable, and personalized treatment plans for low testosterone. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910502249/en/Through a major health platform exclusive collaboration with Marius Pharmaceuticals and more, the company is expanding access to innovative testosterone treatments. An

    9/10/25 9:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Rocket Lab Opens Launch Complex 3, A Critical Milestone On The Path To Neutron's First Launch

    Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today celebrated the official opening of Launch Complex 3, its dedicated test, launch, and landing facility for its reusable rocket Neutron - representing a bold step forward in delivering an alternative, reliable, and responsive launch capability from U.S. soil with its next-generation challenger to the medium-lift launch industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827593085/en/Rocket Lab Launch Complex 3 is declared open by Governor of Virginia Glenn Youngkin (center-left), Rocket Lab CEO

    8/28/25 4:13:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution

    NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index effective prior to the open of trading on Thursday, September 11, to coincide with the semi-annual reconstitution of the index. The B500 contains the 500 most highly capitalized US companies weighted by float market cap, reflecting a market capitalization of $58.19 trillion. Affirm Holdings, Inc. (AFRM), Astera Labs, Inc. (ALAB), The Carlyle Group, Inc. (CG), CyberArk Software, Ltd. (CYBR), EMCOR Group, Inc. (EME), Comfort Systems USA, Inc. (FIX), Insmed,

    8/27/25 4:32:00 PM ET
    $AFRM
    $AKAM
    $ALAB
    Finance: Consumer Services
    Finance
    Real Estate
    Semiconductors

    $HIMS
    $RKLB
    Financials

    Live finance-specific insights

    View All

    Rocket Lab Closes Acquisition of Geost, Expanding Its National Security Capabilities with Launch, Spacecraft, and Now Payloads

    The acquisition expands Rocket Lab's end-to-end mission solutions with advanced electro-optical and infrared payloads for missile warning, tracking, and space domain awareness. Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced it has completed the acquisition of the parent holding company of Geost, LLC ("Geost"), a leading developer of electro-optical and infrared (EO/IR) sensor systems for national security space missions, from Lightridge Solutions, a portfolio company of ATL Partners. The acquisition, first announced on May 27, 2025, was completed for $275 million before closing adjustments, compri

    8/12/25 8:14:00 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Announces Second Quarter 2025 Financial Results, Posts Record Quarterly Revenue of $144m, Representing 36% Year-on-Year Growth, While Expanding Gross Margins 650 Basis Points Year-on-Year

    Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter ended June 30, 2025. Rocket Lab founder and CEO, Sir Peter Beck, said: "Rocket Lab has delivered impressive gross margin expansion and another record revenue result this past quarter, driven by our strong operational performance and program execution that has us on track for a record year of launches and spacecraft delivery. It's also been a busy quarter of M&A activity as we've progressed our acquisition of Geost, strongly positioning ourselves to meet the needs of defense initiatives l

    8/7/25 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results

    Revenue of $544.8 million, up 73% year-over-year in Q2 2025 Net income of $42.5 million; Adjusted EBITDA of $82.2 million in Q2 2025 Subscribers grew to over 2.4 million, up 31% year-over-year in Q2 2025 Affirms full year 2025 revenue guidance of $2.3 billion to $2.4 billion and Adjusted EBITDA guidance of $295 million to $335 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the second quarter ended June 30, 2025, in a shareholder letter that is posted at investors.hims.com. "It's never been more clear that we are delivering exactly what millions of people have been waiti

    8/4/25 4:05:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Leadership Updates

    Live Leadership Updates

    View All

    Rocket Lab Schedules Fifth Electron Mission for Constellation Operator iQPS

    Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the launch window for its next mission for multi-launch customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS), a Japan-based Earth imaging company – marking Electron's 69th mission to date and 11th launch this year. The mission, named ‘The Harvest Goddess Thrives', is scheduled to launch from Rocket Lab Launch Complex 1 in New Zealand during a launch window that opens on August 5, 2025 UTC. The mission will deploy QPS-SAR-12, nicknamed KUSHINADA-I for the Japanese goddess of harvest and prosperity, to a 575km circular Earth orbit to join the re

    7/31/25 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

    Mo Elshenawy joins as the company doubles down on the role AI will play in the next generation of healthcare. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with deep expertise in artificial intelligence and large-scale infrastructure, as the company's new Chief Technology Officer. His appointment marks a key milestone as Hims & Hers accelerates its vision to build the next-generation healthcare platform, powered by AI and designed to deliver deeply personalized, accessible care at scale. This press release features multimedia. View the full release here: https://www.businesswire

    5/8/25 6:50:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer

    Bringing nearly 20 years of global experience at Amazon, Nader Kabbani is joining the executive leadership team to help the company further innovate on the delivery of affordable, seamless personalized care in the U.S. and globally. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A seasoned executive known for scaling trusted consumer and healthcare logistics businesses, Kabbani will oversee operations as the company expands access to personalized care for millions more individuals. This press release features multimedia. View the full release here: https://www.businesswire.com/ne

    5/5/25 9:01:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/3/24 9:39:57 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

    SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    11/12/24 4:45:55 PM ET
    $RKLB
    Military/Government/Technical
    Industrials